⌘K

Login Start Free

Home/Filings/4/0001144204-17-013011

4//SEC Filing

Inspyr Therapeutics, Inc. 4

Accession 0001144204-17-013011

CIK 0001421204operating

View on SEC.gov Company Profile

Filed

Mar 5, 7:00 PM ET

Accepted

Mar 6, 5:18 PM ET

Size

5.5 KB

Accession

0001144204-17-013011

Insider Transaction Report

Form 4

Period: 2017-03-03

Inspyr Therapeutics, Inc.NSPX

OGILVIE SCOTT VARDE

Director

Transactions

Award
Common Stock purchase option
2017-03-03+2,335→ 2,335 total
Exercise: $0.54From: 2017-03-03Exp: 2022-03-03→ Common Stock (2,335 underlying)

Footnotes (1)

[F1]Represents compensatory Annual Grant and Committee Grants for director services. The options vest quarterly on 6/3/17, 9/3/17, 12/3/17, and 3/3/18.

Documents

1 file

4
v461239_form4.xmlPrimary
FORM 4

Issuer

Inspyr Therapeutics, Inc.

CIK 0001421204

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001421204

Filing Metadata

Form type: 4
Filed: Mar 5, 7:00 PM ET
Accepted: Mar 6, 5:18 PM ET
Size: 5.5 KB

View on SEC.gov